QA: Chinook Therapeutics INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2020_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 217,902,000
1 IntangibleAssetsNetIncludingGoodwill 27,145,000
2 PropertyPlantAndEquipmentNet 24,688,000
3 remainder_Assets 21,578,000
4 LiabilitiesCurrent 21,601,000
5 LiabilitiesNoncurrent 199,539,000
6 remainder_Liabilities 4,578,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 34,464,993
9 ResearchAndDevelopmentExpense 60,916,290
10 remainder_Expenses 3,269,618
11 remainder_Revenues 17,030,200
12 remainder_NetIncome 5,530,884
13 remainder_ComprehensiveNetIncome -707,022
  yvar yval
0 Assets 291,313,000
1 Liabilities 225,718,000
2 Expenses 98,650,901
3 Revenues 17,030,200
4 StockholdersEquity 65,595,000
5 NetIncome -76,089,817
6 ComprehensiveNetIncome -76,443,328
7 BaseVar 319,475,004
8 EconomicCapitalRatiobeforeLimitedLiability 0.257
9 EconomicCapitalRatio 1.66

Edgar->Model Mapping

Feature Distribution

Change over Time